Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,689 public trials 1,036 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Iressa Expanded Access Program (EAP)

NCT00034879

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +17 more
Locations
  • Research Site Alabaster, Alabama, United States
  • Research Site Anniston, Alabama, United States
  • Research Site Birmingham, Alabama, United States
  • Research Site Gadsen, Alabama, United States
View all 626 locations
View Trial Details
Completed

Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer

NCT00735904

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations
  • Pfizer Investigational Site Torun, Poland
  • Pfizer Investigational Site Wodzislaw Sl., Poland
  • Pfizer Investigational Site Cluj-Napoca, Cluj, Romania
  • Pfizer Investigational Site Bucharest, Romania
View Trial Details
Completed

Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)

NCT00431015

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Yale Comprehensive Cancer Center New Haven, Connecticut, United States
  • Mount Sinai Comprehensive Cancer Center Miami, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Completed

Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations

NCT00891579

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Lung Cancer Research Institute & Cancer Center of Guangdong General Hospital Guangzhou, Guangdong, China
  • 307 hospital of People's Liberation Army Beijing, China
  • Peking Union Hospital Beijing, China
  • Jilin Tumor Hospital Changchun, China
View Trial Details
Completed

Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)

NCT00132665

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center,Aichi Hospital Okazaki, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • National Hospital Organization Shikoku Cancer Center Natsuyama, Ehime, Japan
View all 37 locations
View Trial Details
Completed

A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer

NCT00482014

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wichita, Kansas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St Louis, Missouri, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States
View Trial Details

Related conditions